Abstract:Since the U.S. Food and Drug Administration (FDA) granted emergency use authorization for two mRNA vaccines against SARS-CoV-2, mRNA-based technology has attracted broad attention from the scientific community to investors. When delivered intracellularly, mRNA has the ability to produce various therapeutic proteins, enabling the treatment of a variety of illnesses, including but not limited to infectious diseases, cancers, and genetic diseases. Accordingly, mRNA holds significant therapeutic potential and provides a promising means to target historically hard-to-treat diseases. Current clinical efforts harnessing mRNA-based technology are focused on vaccination, cancer immunotherapy, protein replacement therapy, and genome editing. The clinical translation of mRNA-based technology has been made possible by leveraging nanoparticle delivery methods. However, the application of mRNA for therapeutic purposes is still challenged by the need for specific, efficient, and safe delivery systems.This Account highlights key advances in designing and developing combinatorial synthetic lipid nanoparticles (LNPs) with distinct chemical structures and properties for in vitro and in vivo intracellular mRNA delivery. LNPs represent the most advanced nonviral nanoparticle delivery systems that have been extensively investigated for nucleic acid delivery. The aforementioned COVID-19 mRNA vaccines and one LNP-based small interfering RNA (siRNA) drug (ONPATTRO) have received clinical approval from the FDA, highlighting the success of synthetic ionizable lipids for in vivo nucleic acid delivery. In this Account, we first summarize the research efforts from our group on the development of bioreducible and biodegradable LNPs by leveraging the combinatorial chemistry strategy, such as the Michael addition reaction, which allows us to easily generate a large set of lipidoids with diverse chemical structures. Next, we discuss the utilization of a library screening strategy to identify optimal LNPs for targeted mRNA delivery and showcase the applications of the optimized LNPs in cell engineering and genome editing. Finally, we outline key challenges to the clinical translation of mRNA-based therapies and propose an outlook for future directions of the chemical design and optimization of LNPs to improve the safety and specificity of mRNA drugs. We hope this Account provides insight into the rational design of LNPs for facilitating the development of mRNA therapeutics, a transformative technology that promises to revolutionize future medicine.

Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo

In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors

A Multidimensional Approach to Modulating Ionizable Lipids for High-Performing and Organ-Selective mRNA Delivery.

Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery

Acid-degradable lipid nanoparticles enhance the delivery of mRNA

Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation

Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery

One‐Component Cationic Lipids for Systemic Mrna Delivery to Splenic T Cells

Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver

Modular Construction of Multifunctional Bioresponsive Cell-Targeted Nanoparticles for Gene Delivery.

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery

Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution

Zwitterionic Polymer-Functionalized Lipid Nanoparticles for the Nebulized Delivery of mRNA

Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing

Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo

Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue Clearance

An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in vivo.

Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery

Targeting Recycling Endosomes to Potentiate mRNA Lipid Nanoparticles